Previous Article | Next Article ![]()
Infection and Immunity, May 1999, p. 2503-2514, Vol. 67, No. 5
Department of Clinical Immunology, The
National University Hospital, Rigshospitalet, Copenhagen, Denmark
Received 19 January 1999/Accepted 24 February 1999
Protective antibodies to the important childhood pathogen
Haemophilus influenzae type b (Hib) are directed
against the capsular polysaccharide (HibCP). Most of the antibody
is encoded by a well-defined set of ("canonical")
immunoglobulin genes, including the V
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Structural Requirements of the Major Protective
Antibody to Haemophilus influenzae Type b
A2 gene, and
expresses an idiotypic marker (HibId-1). In comparison to
noncanonical antibodies, the canonical antibody is generally of higher
avidity, shows higher levels of in vitro bactericidal activity, and is
more protective in infant rats. Using site-directed mutagenesis, we
here characterize canonical HibCP antibodies expressed as
antigen-binding fragments (Fabs) in Escherichia coli,
define amino acids involved in antigen binding and idiotype expression, and propose a three-dimensional structure for the variable
domains. We found that canonical Fabs, unlike a noncanonical Fab, bound effectively to HibCP in the absence of somatic mutations.
Nevertheless, pronounced mutation-based affinity maturation was
demonstrated in vivo. An almost perfect correlation was found between
unmutated gene segments that mediated binding in vitro and those
encoding canonical HibCP antibodies in vivo. Thus, the
V
A2a gene could be replaced by the A2c gene but not by
the highly homologous sister gene, A18b, corresponding to the
demonstrated usage of A2c but not of A18b in vivo. Similarly, only
J
1 and J
3, which predominate in the
response in vivo, were able to facilitate binding in vitro. These
findings suggest that the restricted immunoglobulin gene usage in
HibCP antibodies reflects strict structural demands ensuring
relatively high affinity prior to somatic mutations
requirements met
by only a limited spectrum of immunoglobulin gene combinations.
*
Corresponding author. Mailing address: Department of
Clinical Immunology, sect 7631, National University Hospital,
Tagensvej 20, DK-2200 Copenhagen N, Denmark. Phone: 45 35457631. Fax:
45 35398766. E-mail: hougs{at}biobase.dk.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»